SCHEMBL9998606

SCHEMBL9998606

CCCCCc1ccc(C=C(C(C)C)C(OC(C)=O)OC(C)=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRB P10828 7/20 0.43
ALDH1A1 P00352 1/20 0.42
THRA P10827 6/20 0.42
TNNC1 P63316 5/20 0.42
S1PR1 P21453 2/20 0.42
SGPL1 O95470 1/20 0.42
S1PR4 O95977 1/20 0.42
GPR183 P32249 1/20 0.42
CERS2 Q96G23 1/20 0.42
S1PR3 Q99500 1/20 0.42
S1PR5 Q9H228 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PLA2G1B P04054 2/20 0.40
ATG4B Q9Y4P1 2/20 0.40
CYSLTR2 Q9NS75 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
RARB P10826 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997947 0.99 TNNC1 (0.44) THRBALDH1A1THRATNNC1S1PR1
SCHEMBL9997993 0.99 TNNC1 (0.44) THRBALDH1A1THRATNNC1S1PR1
SCHEMBL9997446 0.99 TNNC1 (0.44) THRBALDH1A1THRATNNC1S1PR1
SCHEMBL9998411 0.99 TNNC1 (0.44) THRBALDH1A1THRATNNC1S1PR1
SCHEMBL9997835 0.99 TNNC1 (0.44) THRBALDH1A1THRATNNC1S1PR1
SCHEMBL9997406 0.96 ALDH1A1 (0.41) THRBALDH1A1THRATNNC1S1PR1
SCHEMBL9998014 0.91 THRB (0.39) THRBALDH1A1S1PR1S1PR3KMT2A
SCHEMBL9997699 0.87 THRB (0.45) THRBALDH1A1THRAMEN1KMT2A
SCHEMBL9997702 0.87 THRB (0.45) THRBALDH1A1THRAMEN1KMT2A
SCHEMBL9997592 0.86 THRB (0.45) THRBALDH1A1THRAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 THRB 926/4885ALDH1A1 160/4885THRA 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.